HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Rapid Responses: Submit a response Alert me when this article is cited Alert me when Rapid Responses are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Google Scholar Articles by Ferris, D. G. Articles by Smith, J. PubMed PubMed Citation Articles by Ferris, D. G. Articles by Smith, J.

HPV Vaccine Acceptance Among Mid-Adult Women

Gynecologic Prevention Center (DGF); the Department of Family Medicine and the Department of Obstetrics and Gynecology (DGF)
Department of Biostatistics (JLW), Augusta, Georgia
Medical College of Georgia (AO), Augusta, Georgia
Paine College (JS), Augusta, Georgia

Correspondence: Corresponding author: Daron G. Ferris, MD, Department of Family Medicine, Medical College of Georgia, 1423 Harper Street, HH-105, Augusta, GA, 30912 (E-mail:agerman{at}mcg.edu)

Objective: To determine correlates of human papillomavirus (HPV) vaccine acceptance in mid-adult women.

Methods: A convenience sample of 472 mid-adult women completed a 2-part, 69-item survey that included demographic, knowledge, and behavioral variables as potential correlates of vaccine acceptance. Univariable and multivariable logistic regression models were used to identify correlates for vaccine acceptance.

Results: Mid-adult women who received the HPV vaccine were more likely to be younger than 55 years (P < .001); have had an abnormal Papanicolaou test (odds ratio [OR], 2.15; 95% CI, 1.18–3.92); understand that HPV causes cervical cancer (OR, 2.39; 95% CI, 1.08–5.30); feel at risk for HPV infection (OR, 2.14; 95% CI, 1.00–4.57), and feel it is important for their partner (OR, 25.20; 95% CI, 9.66–65.72) and children (OR, 3.54; CI, 0.51–24.56) to get the HPV vaccine. Monogamous mid-adult women (OR, 0.46; 95% CI, 0.21–1.00); women who did not want any vaccines (OR, 0.26; 95% CI, 0.07–0.92); and women who felt it was too late to get the vaccine (OR, 0.18; 95% CI, 0.08–0.44) were less likely to want the HPV vaccine.

Conclusions: These clinical predictors of HPV vaccine acceptance will help clinicians recognize mid-adult women who may be more receptive to vaccination.

This article has been cited by other articles:

				M. A. Bowman and A. V. Neale North American Primary Care Research Group President's Award J Am Board Fam Med, January 1, 2008; 21(1): 1 - 3. [Full Text] [PDF]